logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Class Action
    • Eminent Domain
    • Medical Malpractice
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Appellate Law
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
  • Firm News
    • News & Announcements
    • Alerts
  • Blog
  • Contact Us

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Class Action
    • Eminent Domain
    • Medical Malpractice
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Appellate Law
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
  • Firm News
    • News & Announcements
    • Alerts
  • Blog
  • Contact Us

Home » FDA Issues Warning for Invokana Amputation Risk

FDA Issues Warning for Invokana Amputation Risk

The U.S. Food and Drug Administration (FDA) issued a drug safety announcement on May 16, 2017 that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations.  The announcement was based on new data from two large clinical trials.   As a result of the data from the two clinical trials, the FDA required new warnings, including a black box warning for the risk of amputation.

Talk to your health care professional if you have questions or concerns. Do not stop taking your diabetes medicine without first talking to your health care professional.

The lawyers of Cohen and Malad, LLP are currently investigating cases involving amputations for patients taking Invokana, Invokamet, or Invokamet XR.  If you or a loved one had an amputation of your leg or foot while taking Invokana, Invokamet, or Invokamet XR, please contact us and we will investigate your case.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Citizens Equity First Credit Union Faces Lawsuit Over Improper Overdraft Fees

Cohen & Malad, LLP filed a class action lawsuit against Citizens Equity First Credit Union (CEFCU) for allegedly .. [Read More]

SEE ALL ALERTS

In the News

Twelve Cohen & Malad, LLP Attorneys Named to 2019 Indiana Super Lawyers List Six Cohen & Malad, LLP Attorneys Named To 2019 Indiana Super Lawyers Rising Stars List Cohen & Malad, LLP Selected to Join Greenwood Business Launch Team
READ OUR NEWS